first International Rare Disease Research Consortium Conference in Dublin
After its launch in April 2011, IRDiRC has garnered significant support around the globe. To begin with, three projects of the IRDiRC flagship venture have been granted around 40 million euros under the European FP7 plan. The goal of IRDiRC is to assist in delivering 200 new therapies for rare diseases and means to diagnose most rare diseases by the year 2020. The conference in Dublin will play a substantial role in advancing to these goals.
Organised by the European Commission in association with the Irish presidency of the Council of the European Union, the IRDiRC conference registration is now open to the public.
Learn more about IRDiRC